| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $97,989,839 ) (Continued on the next page) |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122546 | Mechanisms of Sonic Hedgehog Signal Transduction | 000 | 9 | NIH | 7/10/2026 | $500,500 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM118041 | REGULATION OF XENOBIOTIC RECEPTORS PXR AND CAR, AND CYP3A: IMPLICATIONS IN DRUG DISPOSITION | 002 | 11 | NIH | 5/20/2026 | $555,000 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01HG013981 | Deciphering the underlying structure of the glucocorticoid gene regulatory network | 000 | 2 | NIH | 4/1/2026 | $816,511 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32CA225590 | Training in Pediatric Cancer Survivorship Outcomes and Interventions | 000 | 9 | NIH | 7/30/2026 | $315,339 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | UM1CA081457 | Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | 001 | 25 | NIH | 4/29/2026 | $1,423,203 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 001 | 14 | NIH | 4/16/2026 | $45,043 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 000 | 14 | NIH | 1/27/2026 | $405,403 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25CA023944 | PEDIATRIC ONCOLOGY EDUCATION (YEARS 38 - 42) | 001 | 42 | NIH | 5/5/2026 | $432,000 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 002 | 22 | NIH | 3/26/2026 | $522,945 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | P30CA021765 | Cancer Center Support Grant (CCSG) | 000 | 47 | NIH | 4/17/2026 | $6,752,102 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 002 | 32 | NIH | 4/16/2026 | $442,768 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 001 | 32 | NIH | 2/20/2026 | $325,043 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 000 | 32 | NIH | 2/10/2026 | $3,984,912 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI128756 | Bioactivities of pneumococcal cell wall in neuropathogenesis | 000 | 10 | NIH | 1/6/2026 | $455,000 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01HL156647 | Base editing and prime editing for sickle cell disease | 001 | 6 | NIH | 8/4/2026 | $765,484 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG075869 | REGULATION OF PROTEOSTASIS AND TAUOPATHY BY MALTOSE-INDUCED SIGNALING | 000 | 3 | NIH | 2/26/2026 | $462,500 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37AI105887 | Metabolic checkpoint in dendritic cell subsets and adaptive immunity | 000 | 13 | NIH | 1/26/2026 | $455,000 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01DK140461 | Extracellular matrix in vertebrate hematopoietic stem cell specification | 000 | 3 | NIH | 6/19/2026 | $370,000 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY037117 | The Role of Müller Glia in Acute and Chronic Response to Stress, Injury, and Disease in the Retina | 000 | 2 | NIH | 1/30/2026 | $606,034 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA289881 | Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity | 001 | 2 | NIH | 4/16/2026 | $69,686 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA289881 | Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity | 000 | 2 | NIH | 12/23/2025 | $627,177 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA290805 | Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy | 000 | 2 | NIH | 12/23/2025 | $645,099 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA290805 | Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy | 001 | 2 | NIH | 4/16/2026 | $71,677 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM157243 | Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics | 001 | 2 | NIH | 3/23/2026 | $46,250 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM157243 | Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics | 000 | 2 | NIH | 1/15/2026 | $416,250 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA263969 | In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas | 001 | 5 | NIH | 7/27/2026 | $383,681 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM155423 | Chemical approaches for targeting ribonucleoprotein assemblies | 000 | 3 | NIH | 8/14/2026 | $462,500 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32HL176447 | Basic and Translational Research Training in Pediatric Classical Hematology | 001 | 2 | NIH | 5/14/2026 | $4,044 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32HL176447 | Basic and Translational Research Training in Pediatric Classical Hematology | 000 | 2 | NIH | 2/20/2026 | $250,704 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121114 | Understanding the Sequence and Structural Determinants of Phase Behavior of ALS-Causing Proteins | 002 | 6 | NIH | 8/7/2026 | $697,992 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01DC021511 | Sensory-evoked adenosine release in cortical plasticity | 000 | 3 | NIH | 5/18/2026 | $561,784 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI170765 | Targeting NuoD for the treatment of H. pylori | 000 | 4 | NIH | 5/7/2026 | $844,980 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI168214 | Consequences of Direct Viral-Bacterial Interactions | 000 | 5 | NIH | 12/31/2025 | $502,279 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH136215 | Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | 000 | 2 | NIH | 3/24/2026 | $623,312 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS139519 | Polarity Signals Coordinate Neuronal Differentiation & Nuclear Organization | 001 | 2 | NIH | 2/26/2026 | $67,638 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS139519 | Polarity Signals Coordinate Neuronal Differentiation & Nuclear Organization | 000 | 2 | NIH | 1/14/2026 | $608,750 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI131703 | Regulation of T cell memory in tissue immunity | 000 | 7 | NIH | 11/26/2025 | $555,000 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122462 | Structure and functional mechanisms of molecular chaperones and protein kinases | 000 | 10 | NIH | 2/17/2026 | $764,284 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM144566 | Structural Basis of Programmable DNA-Insertion via Cryo-EM Studies of CRISPR-Associated TnsC | 000 | 5 | NIH | 1/9/2026 | $343,981 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25GM150178 | Memphis STEM-M Ambassadors | 000 | 4 | NIH | 8/20/2026 | $255,223 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM144566 | Structural Basis of Programmable DNA-Insertion via Cryo-EM Studies of CRISPR-Associated TnsC | 001 | 5 | NIH | 3/19/2026 | $38,219 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA294103 | Discovering the mechanisms underlying oncogenesis by ZFTA-RELA and pinpointing therapeutic targets. | 000 | 3 | NIH | 8/4/2026 | $538,937 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY036689 | The Role of Modular Super-Enhancers in the Developing Murine and Human Retina | 000 | 3 | NIH | 4/28/2026 | $596,514 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA281823 | Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma | 000 | 4 | NIH | 8/12/2026 | $786,304 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K23HL166697 | School Readiness Intervention for Preschool Children with Sickle Cell Disease | 000 | 4 | NIH | 4/24/2026 | $163,886 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA266600 | EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA | 000 | 5 | NIH | 6/18/2026 | $691,425 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI165426 | Antibiotic tolerance: membraneless organelles and autolysin regulation | 000 | 5 | NIH | 6/3/2026 | $455,000 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA260060 | Developing new therapeutic strategies for pediatric tumors that lack clinically actionable mutations | 001 | 6 | NIH | 6/5/2026 | $597,537 |
| | 2026 | 2026 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS116361 | Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven Glioma | 000 | 5 | NIH | 3/6/2026 | $476,139 |
|
